PTC Therapeutics
PTCT
#2991
Rank
HK$42.66 B
Marketcap
HK$511.19
Share price
0.29%
Change (1 day)
8.31%
Change (1 year)

Earnings for PTC Therapeutics (PTCT)

Earnings in 2026 (TTM): -HK$0.52 Billion

According to PTC Therapeutics 's latest financial reports the company's current earnings are HK$1.00 Billion. In 2025 the company made an earning of HK$5.46 Billion, an increase over its 2024 earnings that were of -HK$2.85 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for PTC Therapeutics from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$0.52 Billion-109.44%
2025 HK$5.46 B-291.84%
2024 -HK$2.85 Billion-47.84%
2023 -HK$5.47 Billion18.49%
2022 -HK$4.61 Billion13.34%
2021 -HK$4.07 Billion28.64%
2020 -HK$3.17 Billion67.94%
2019 -HK$1.89 Billion87.28%
2018 -HK$1.01 Billion64.95%
2017 -HK$0.61 Billion-45.13%
2016 -HK$1.12 Billion-16.72%
2015 -HK$1.34 Billion72.64%
2014 -HK$0.78 Billion90.89%
2013 -HK$0.41 Billion96.58%
2012 -HK$0.21 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
HK$121.79 B-23,241.60%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
HK$39.57 B-7,619.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-HK$1.27 Billion 139.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-HK$1.03 Billion 95.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
-HK$1.05 Billion 99.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
-HK$5.38 Billion 920.71%๐Ÿ‡บ๐Ÿ‡ธ USA